0 XP   0   0   0

Esperite N.V










Financial Health of Esperite




Comparing to competitors in the Medical Care Facilities industry




  Industry Rankings  


Esperite N.V
Buy, Hold or Sell?

Should you buy, hold or sell Esperite?

I guess you are interested in Esperite N.V. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Esperite

Let's start. I'm going to help you getting a better view of Esperite N.V. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Esperite N.V even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Esperite N.V is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Esperite N.V. The closing price on 2022-10-28 was €0.0092 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Esperite N.V Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Esperite N.V.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Esperite earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Esperite to the Medical Care Facilities industry mean.
  • A Net Profit Margin of -168.7% means that €-1.69 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Esperite N.V:

  • The MRQ is -168.7%. The company is making a huge loss. -2
  • The TTM is -143.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-168.7%TTM-143.5%-25.3%
TTM-143.5%YOY-42.9%-100.6%
TTM-143.5%5Y-93.2%-50.3%
5Y-93.2%10Y-93.2%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-168.7%2.9%-171.6%
TTM-143.5%2.9%-146.4%
YOY-42.9%2.8%-45.7%
5Y-93.2%2.3%-95.5%
10Y-93.2%2.7%-95.9%
1.1.2. Return on Assets

Shows how efficient Esperite is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Esperite to the Medical Care Facilities industry mean.
  • -15.9% Return on Assets means that Esperite generated €-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Esperite N.V:

  • The MRQ is -15.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.9%TTM-15.1%-0.7%
TTM-15.1%YOY-5.2%-10.0%
TTM-15.1%5Y-10.2%-5.0%
5Y-10.2%10Y-10.2%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.9%0.6%-16.5%
TTM-15.1%0.7%-15.8%
YOY-5.2%0.7%-5.9%
5Y-10.2%0.7%-10.9%
10Y-10.2%0.6%-10.8%
1.1.3. Return on Equity

Shows how efficient Esperite is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Esperite to the Medical Care Facilities industry mean.
  • 0.0% Return on Equity means Esperite generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Esperite N.V:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-174.5%+174.5%
TTM-174.5%YOY-30.8%-143.7%
TTM-174.5%5Y-102.6%-71.8%
5Y-102.6%10Y-102.6%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.8%-1.8%
TTM-174.5%2.2%-176.7%
YOY-30.8%2.0%-32.8%
5Y-102.6%1.6%-104.2%
10Y-102.6%1.7%-104.3%

1.2. Operating Efficiency of Esperite N.V.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Esperite is operating .

  • Measures how much profit Esperite makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Esperite to the Medical Care Facilities industry mean.
  • An Operating Margin of -106.9% means the company generated €-1.07  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Esperite N.V:

  • The MRQ is -106.9%. The company is operating very inefficient. -2
  • The TTM is -70.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-106.9%TTM-70.6%-36.3%
TTM-70.6%YOY-48.7%-21.9%
TTM-70.6%5Y-59.6%-11.0%
5Y-59.6%10Y-59.6%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-106.9%5.7%-112.6%
TTM-70.6%3.7%-74.3%
YOY-48.7%4.5%-53.2%
5Y-59.6%4.7%-64.3%
10Y-59.6%5.2%-64.8%
1.2.2. Operating Ratio

Measures how efficient Esperite is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 2.49 means that the operating costs are €2.49 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Esperite N.V:

  • The MRQ is 2.490. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.054. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.490TTM2.054+0.436
TTM2.054YOY1.915+0.139
TTM2.0545Y1.984+0.069
5Y1.98410Y1.9840.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4901.215+1.275
TTM2.0541.152+0.902
YOY1.9150.996+0.919
5Y1.9841.031+0.953
10Y1.9841.006+0.978

1.3. Liquidity of Esperite N.V.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Esperite is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 0.52 means the company has €0.52 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Esperite N.V:

  • The MRQ is 0.519. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.541. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.519TTM0.541-0.022
TTM0.541YOY0.606-0.064
TTM0.5415Y0.574-0.032
5Y0.57410Y0.5740.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5191.349-0.830
TTM0.5411.337-0.796
YOY0.6061.294-0.688
5Y0.5741.332-0.758
10Y0.5741.324-0.750
1.3.2. Quick Ratio

Measures if Esperite is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Esperite to the Medical Care Facilities industry mean.
  • A Quick Ratio of 0.41 means the company can pay off €0.41 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Esperite N.V:

  • The MRQ is 0.406. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.407. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.406TTM0.407-0.001
TTM0.407YOY0.533-0.125
TTM0.4075Y0.470-0.063
5Y0.47010Y0.4700.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4060.787-0.381
TTM0.4070.831-0.424
YOY0.5330.861-0.328
5Y0.4700.922-0.452
10Y0.4700.868-0.398

1.4. Solvency of Esperite N.V.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Esperite assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Esperite to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 1.11 means that Esperite assets are financed with 110.7% credit (debt) and the remaining percentage (100% - 110.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Esperite N.V:

  • The MRQ is 1.107. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.039. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.107TTM1.039+0.068
TTM1.039YOY0.836+0.203
TTM1.0395Y0.938+0.101
5Y0.93810Y0.9380.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1070.548+0.559
TTM1.0390.540+0.499
YOY0.8360.559+0.277
5Y0.9380.532+0.406
10Y0.9380.522+0.416
1.4.2. Debt to Equity Ratio

Measures if Esperite is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Esperite to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Esperite N.V:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM11.755-11.755
TTM11.755YOY4.922+6.832
TTM11.7555Y8.338+3.416
5Y8.33810Y8.3380.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.050-1.050
TTM11.7551.039+10.716
YOY4.9221.252+3.670
5Y8.3381.159+7.179
10Y8.3381.132+7.206

2. Market Valuation of Esperite N.V

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Esperite generates.

  • Above 15 is considered overpriced but always compare Esperite to the Medical Care Facilities industry mean.
  • A PE ratio of -5.17 means the investor is paying €-5.17 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Esperite N.V:

  • The EOD is -0.159. Company is losing money. -2
  • The MRQ is -5.172. Company is losing money. -2
  • The TTM is -7.647. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.159MRQ-5.172+5.013
MRQ-5.172TTM-7.647+2.475
TTM-7.647YOY-41.071+33.424
TTM-7.6475Y-24.359+16.712
5Y-24.35910Y-24.3590.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-0.15940.641-40.800
MRQ-5.17243.859-49.031
TTM-7.64747.904-55.551
YOY-41.07147.028-88.099
5Y-24.35950.019-74.378
10Y-24.35951.628-75.987

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Esperite is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of -7.67 means the investor is paying €-7.67 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Esperite N.V:

  • The EOD is -0.236. Bad. Book ratio is negative. -2
  • The MRQ is -7.668. Bad. Book ratio is negative. -2
  • The TTM is 18.968. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD-0.236MRQ-7.668+7.433
MRQ-7.668TTM18.968-26.636
TTM18.968YOY12.450+6.518
TTM18.9685Y15.709+3.259
5Y15.70910Y15.7090.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-0.2362.005-2.241
MRQ-7.6682.184-9.852
TTM18.9682.343+16.625
YOY12.4502.392+10.058
5Y15.7092.129+13.580
10Y15.7092.069+13.640
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Esperite N.V compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.0330%0.023-100%-0.0050%-0.0050%
Book Value Growth--0.053-2.030+3923%-0.029+154%-1.172+2308%-1.172+2308%
Book Value Per Share---0.039-0.013-66%0.090-144%0.038-202%0.038-202%
Book Value Per Share Growth----1.9280%0.023-100%-1.0920%-1.0920%
Current Ratio--0.5190.541-4%0.606-14%0.574-9%0.574-9%
Debt To Asset Ratio--1.1071.039+7%0.836+32%0.938+18%0.938+18%
Debt To Equity Ratio---11.755-100%4.922-100%8.338-100%8.338-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.058-0.061+5%-0.028-51%-0.044-23%-0.044-23%
Eps Growth----0.1510%0.323-100%0.052-100%0.052-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---1.687-1.435-15%-0.429-75%-0.932-45%-0.932-45%
Operating Margin---1.069-0.706-34%-0.487-54%-0.596-44%-0.596-44%
Operating Ratio--2.4902.054+21%1.915+30%1.984+25%1.984+25%
Pb Ratio-0.236+97%-7.66818.968-140%12.450-162%15.709-149%15.709-149%
Pe Ratio-0.159+97%-5.172-7.647+48%-41.071+694%-24.359+371%-24.359+371%
Price Per Share0.009-3155%0.3000.468-36%1.107-73%0.787-62%0.787-62%
Profit Growth--5.310-10.641+300%39.307-86%10.765-51%10.765-51%
Quick Ratio--0.4060.4070%0.533-24%0.470-14%0.470-14%
Return On Assets---0.159-0.151-5%-0.052-67%-0.102-36%-0.102-36%
Return On Equity----1.7450%-0.3080%-1.0260%-1.0260%
Revenue Growth---0.053-0.201+278%-0.191+261%-0.197+271%-0.197+271%
Total Gains Per Share----0.0330%0.023-100%-0.0050%-0.0050%
Usd Book Value---3177202.700-1077847.850-66%7286925.450-144%3104538.800-202%3104538.800-202%
Usd Book Value Change Per Share----0.0350%0.024-100%-0.0050%-0.0050%
Usd Book Value Per Share---0.041-0.014-66%0.094-144%0.040-202%0.040-202%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.061-0.064+5%-0.030-51%-0.047-23%-0.047-23%
Usd Price Per Share0.010-3155%0.3150.492-36%1.165-73%0.829-62%0.829-62%
Usd Profit---4711042.850-4927981.450+5%-2306289.000-51%-3617135.225-23%-3617135.225-23%
Usd Revenue--2791768.1003571588.650-22%5224955.650-47%4398272.150-37%4398272.150-37%
Usd Total Gains Per Share----0.0350%0.024-100%-0.0050%-0.0050%
 EOD+1 -3MRQTTM+9 -13YOY+5 -235Y+5 -1810Y+5 -18

3.2. Fundamental Score

Let's check the fundamental score of Esperite N.V based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.159
Price to Book Ratio (EOD)Between0-1-0.236
Net Profit Margin (MRQ)Greater than0-1.687
Operating Margin (MRQ)Greater than0-1.069
Quick Ratio (MRQ)Greater than10.406
Current Ratio (MRQ)Greater than10.519
Debt to Asset Ratio (MRQ)Less than11.107
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.159
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Esperite N.V based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.676
Ma 20Greater thanMa 500.011
Ma 50Greater thanMa 1000.014
Ma 100Greater thanMa 2000.018
OpenGreater thanClose0.010
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2018-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets28,192
Total Liabilities31,209
Total Stockholder Equity-2,587
 As reported
Total Liabilities 31,209
Total Stockholder Equity+ -2,587
Total Assets = 28,192

Assets

Total Assets28,192
Total Current Assets7,284
Long-term Assets7,284
Total Current Assets
Cash And Cash Equivalents 1,336
Net Receivables 5,700
Inventory 248
Total Current Assets  (as reported)7,284
Total Current Assets  (calculated)7,284
+/-0
Long-term Assets
Property Plant Equipment 3,094
Intangible Assets 14,403
Long-term Assets  (as reported)0
Long-term Assets  (calculated)17,497
+/- 17,497

Liabilities & Shareholders' Equity

Total Current Liabilities14,026
Long-term Liabilities-
Total Stockholder Equity-2,587
Total Current Liabilities
Short-term Debt 3
Short Long Term Debt 3
Accounts payable 12,841
Other Current Liabilities 1,182
Total Current Liabilities  (as reported)14,026
Total Current Liabilities  (calculated)14,029
+/- 3
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock3,316
Other Stockholders Equity -6,542
Total Stockholder Equity (as reported)-2,587
Total Stockholder Equity (calculated)-3,226
+/- 639
Other
Net Tangible Assets -16,990



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
> Total Assets 
42,480
42,480
42,156
42,156
33,883
33,883
28,192
28,192
28,19228,19233,88333,88342,15642,15642,48042,480
   > Total Current Assets 
9,542
9,542
9,612
9,612
8,200
8,200
7,284
7,284
7,2847,2848,2008,2009,6129,6129,5429,542
       Cash And Cash Equivalents 
910
910
729
729
694
694
1,336
1,336
1,3361,336694694729729910910
       Net Receivables 
8,070
8,070
8,751
8,751
5,940
5,940
5,700
5,700
5,7005,7005,9405,9408,7518,7518,0708,070
       Inventory 
350
350
132
132
256
256
248
248
248248256256132132350350
   > Long-term Assets 00000000
       Property Plant Equipment 
9,554
9,554
8,976
8,976
6,742
6,742
3,094
3,094
3,0943,0946,7426,7428,9768,9769,5549,554
       Goodwill 
14,686
14,686
0
0
11,612
11,612
0
0
0011,61211,6120014,68614,686
       Long Term Investments 
0
0
0
0
165
165
0
0
001651650000
       Intangible Assets 
5,017
5,017
18,177
18,177
3,259
3,259
14,403
14,403
14,40314,4033,2593,25918,17718,1775,0175,017
> Total Liabilities 
35,809
35,809
34,988
34,988
32,913
32,913
31,209
31,209
31,20931,20932,91332,91334,98834,98835,80935,809
   > Total Current Liabilities 
16,440
16,440
15,229
15,229
14,554
14,554
14,026
14,026
14,02614,02614,55414,55415,22915,22916,44016,440
       Short-term Debt 
5,574
5,574
5,545
5,545
210
210
3
3
332102105,5455,5455,5745,574
       Short Long Term Debt 
5,574
5,574
5,545
5,545
210
210
3
3
332102105,5455,5455,5745,574
       Accounts payable 
8,642
8,642
12,288
12,288
6,123
6,123
12,841
12,841
12,84112,8416,1236,12312,28812,2888,6428,642
       Other Current Liabilities 
4,744
4,744
2,678
2,678
5,611
5,611
1,182
1,182
1,1821,1825,6115,6112,6782,6784,7444,744
   > Long-term Liabilities 00000000
> Total Stockholder Equity
6,939
6,939
7,470
7,470
1,400
1,400
-2,587
-2,587
-2,587-2,5871,4001,4007,4707,4706,9396,939
   Common Stock
1,038
1,038
1,387
1,387
1,922
1,922
3,316
3,316
3,3163,3161,9221,9221,3871,3871,0381,038
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity -6,542-6,542-1,909-1,909-1,927-1,927-1,958-1,958



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2018-12-31)

Gross Profit (+$)
totalRevenue11,841
Cost of Revenue-4,304
Gross Profit7,5377,537
 
Operating Income (+$)
Gross Profit7,537
Operating Expense-30,781
Operating Income-18,940-23,244
 
Operating Expense (+$)
Research Development4
Selling General Administrative24,561
Selling And Marketing Expenses-
Operating Expense30,78124,565
 
Net Interest Income (+$)
Interest Income87
Interest Expense-992
Net Interest Income-1,399-905
 
Pretax Income (+$)
Operating Income-18,940
Net Interest Income-1,399
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-18,549-18,940
EBIT - interestExpense = -16,637
-18,479
-17,487
Interest Expense992
Earnings Before Interest and Taxes (ebit)-15,645-17,557
Earnings Before Interest and Taxes (ebitda)-15,645
 
After tax Income (+$)
Income Before Tax-18,549
Tax Provision--69
Net Income From Continuing Ops-18,479-18,480
Net Income-18,479
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,399
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
DISHTV.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DISHTV.BSE.

DISHTV.BSE Daily Candlestick Chart
DFM.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DFM.BSE.

DFM.BSE Daily Candlestick Chart
CHANDNI.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHANDNI.BSE.

CHANDNI.BSE Daily Candlestick Chart
CEATLTD.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CEATLTD.BSE.

CEATLTD.BSE Daily Candlestick Chart
AXISBANK.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AXISBANK.BSE.

AXISBANK.BSE Daily Candlestick Chart
ASHOKA.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASHOKA.BSE.

ASHOKA.BSE Daily Candlestick Chart
ALFAVIO.BSE
22 hours ago

I found you a Death Cross on the daily chart of ALFAVIO.BSE.

ALFAVIO.BSE Daily Candlestick Chart
AJMERA.BSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AJMERA.BSE.

AJMERA.BSE Daily Candlestick Chart
HCM.LSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HCM.LSE.

HCM.LSE Daily Candlestick Chart
DOCS.LSE
22 hours ago

I found you a Death Cross on the daily chart of DOCS.LSE.

DOCS.LSE Daily Candlestick Chart
RMAP.LSE
22 hours ago

I found you a Death Cross on the daily chart of RMAP.LSE.

RMAP.LSE Daily Candlestick Chart
CPH2.LSE
22 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of CPH2.LSE.

CPH2.LSE Daily Candlestick Chart
ABF.LSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ABF.LSE.

ABF.LSE Daily Candlestick Chart
DOM.LSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DOM.LSE.

DOM.LSE Daily Candlestick Chart
DNLM.LSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DNLM.LSE.

DNLM.LSE Daily Candlestick Chart
FCRM.LSE
22 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of FCRM.LSE.

FCRM.LSE Daily Candlestick Chart
XLPS.LSE
22 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XLPS.LSE.

XLPS.LSE Daily Candlestick Chart
PHGP.LSE
22 hours ago

I found you a Death Cross on the daily chart of PHGP.LSE.

PHGP.LSE Daily Candlestick Chart
EMLI.LSE
23 hours ago

I found you a Golden Cross on the daily chart of EMLI.LSE.

EMLI.LSE Daily Candlestick Chart
SLVR.LSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SLVR.LSE.

SLVR.LSE Daily Candlestick Chart
GBAL.TO
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GBAL.TO.

GBAL.TO Daily Candlestick Chart
ACC.BSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ACC.BSE.

ACC.BSE Daily Candlestick Chart
VRL.BSE
23 hours ago

I found you a Golden Cross on the daily chart of VRL.BSE.

VRL.BSE Daily Candlestick Chart
CANDOUR.BSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CANDOUR.BSE.

CANDOUR.BSE Daily Candlestick Chart